Otros idiomas Hua Medicine (Shanghai) Ltd. OTC Markets

Acciones

HUMDF

KYG4644K1022

Mercado cerrado - OTC Markets Otros sitios de cotización 19:33:26 07/06/2023			Varia. Cinco días.	Varia. 1 de enero.
0,2028 ^USD	-54,93 %		-.--%	-.--%

28/03	Hua Medicine (Shanghai) Ltd. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
2023	Hua Medicine (Shanghai) Ltd. Nombra a Yi Zhang Director Ejecutivo con efecto a partir del 1 de enero de 2024	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024	29/12
Hua Medicine Intends to Conduct Trials of Diabetes Drug in US	21/12
Hua Medicine Submits Investigational New Drug Application with the U.S. Food and Drug Administration for the 2Nd Generation Glucokinase Allosteric Activator	21/12
China Includes Hua Medicine's Type 2 Diabetes Medication in Drug Reimbursement List	14/12
Hua Medicine's Unit Receives 800 Million Yuan for Development of Diabetes Drug	22/11
Hua Medicine Ltd. Announces Board and Committee Changes	12/10/23
Transcript : Hua Medicine Ltd., Q2 2023 Earnings Call, Aug 25, 2023	25/08/23
Hua Medicine Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Hua Medicine Signs Distribution Agreement with Digital Healthcare Platform	11/04/23
Hua Medicine Ltd. Announces Resignation of Mr. Junling Liu as Independent Non-Executive Director and Change in Composition of the Board Committees	31/03/23
Transcript : Hua Medicine Ltd., 2022 Earnings Call, Mar 30, 2023	30/03/23
Hua Medicine Shrinks Loss in 2022 as Revenue Witnesses a Boost	29/03/23
Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23
Hua Medicine Makes 49 Million Yuan of HuaTangNing Sales Since Launch	17/02/23
Hua Medicine Receives 400 Million Yuan in Milestone Payments for Diabetes Treatment	08/02/23
Hua Medicine Ltd. Announces Directorate and Committee Changes	30/12/22
Hua Medicine Announces Demise of Walter Teh-Ming Kwauk, an Independent Non-Executive Director	24/11/22
Hua Medicine Unit Buys 100% Stake in Diabetes Drug Research Company	18/11/22
China OKs Hua Medicine's New Drug Application for Type 2 Diabetes Treatment; Shares slipped 11%	10/10/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Hua Medicine (Shanghai) Ltd. OTC Markets

Acciones

HUMDF

KYG4644K1022

Otros idiomas

Filtros